![Andrew Gengos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 52 000 $ in data 31/05/2026
Andrew W.
Gengos is currently Director at Turn Therapeutics (TM), Inc., Independent Director at Turn Therapeutics, Inc. since 2020, Director at Seneca Therapeutics, Inc. starting 2025, and Chief Financial & Accounting Officer at Terns Pharmaceuticals, Inc. starting 2025.
Former positions include President, Chief Executive Officer & Director at ImmunoCellular Therapeutics Ltd. from 2012 to 2016; President, Chief Executive Officer & Director at Neuraltus Pharmaceuticals, Inc. from 2010 to 2012; Director at Allozyne, Inc.; Vice President-Strategy & Corporate Development at Amgen, Inc. from 2002 to 2010; Vice President-Strategy & Development at Chiron Corp.
in 2010; Chief Financial & Business Officer at Dynavax Technologies Corp.; Senior Manager-Engagement at McKinsey & Co., Inc. from 1991 to 1998; Vice President-Strategy & Corporate Development at Relypsa, Inc. in 2010; Chief Business Officer at Cyteir Therapeutics, Inc. from 2020 to 2023; COO & Head-Corporate Development at Synlogic, Inc. from 2017 to 2018; Chief Financial & Business Officer at AOBiome Therapeutics, Inc. in 2019; and Chief Financial & Business Officer at LeonaBio, Inc. from 2023 to 2024.
Education includes undergraduate studies at Massachusetts Institute of Technology and an MBA from UCLA Anderson School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/06/2026 | 10.000 ( 0,03% ) | 52 000 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 24/02/2025 |
| TURN THERAPEUTICS INC. | Direttore/Membro del Consiglio | 01/01/2020 |
Turn Therapeutics(TM), Inc
 Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Direttore/Membro del Consiglio | - |
Seneca Therapeutics, Inc.
 Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel oncolytic immunotherapeutics | Direttore/Membro del Consiglio | 01/03/2025 |
| Società | Posizione | Fine |
|---|---|---|
| LEONABIO, INC. | Direttore Finanziario/CFO | 01/10/2024 |
| CYTEIR THERAPEUTICS, INC. | Corporate Officer/Principal | 03/02/2023 |
AOBiome Therapeutics, Inc.
 AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions | Direttore Finanziario/CFO | 01/12/2019 |
| SYNLOGIC, INC. | Direttore operativo | 01/12/2018 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Amministratore Delegato | 01/12/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 18 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Neuraltus Pharmaceuticals, Inc.
 Neuraltus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes molecule therapeutics | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
AOBiome Therapeutics, Inc.
AOBiome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops microbiome-targeted therapies for local, nasal and systemic inflammatory conditions | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops novel oncolytic immunotherapeutics | Commercial Services |
Turn Therapeutics(TM), Inc
Turn Therapeutics(TM), Inc Medical SpecialtiesHealth Technology Develops antibiotic resistance medicines | Health Technology |
Global Health Solutions Inc
 Global Health Solutions Inc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and medical device development company that provides solutions for dermatological diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
